Pharmafile Logo
Pharmafocus logo
Advanced Search
gilead-sciences

Gilead’s filgotinib combos fall short in lupus and Sjögren’s syndrome

October 28, 2019
Research and Development, Sales and Marketing Gilead, Lupus, filgotinib, pharma

Gilead’s impending regulatory submission of its JAK inhibitor filgotinib to the FDA for the treatment of rheumatoid arthritis has been …

News
shutter

UKRI and BBSRC award £170m to 3 UK universities for biotech and biology PhD studentships

October 28, 2019
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing UK, pharma, research

The Biotechnology and Biological Sciences Research Council (BBSRC) and UK Research and Innovation (UKRI) have awarded a funding injection of …

News
shutterstock_138095450

Ovarian cancer market set to smash $6.7 billion by 2025

October 28, 2019
Sales and Marketing Cancer, GlobalData, ovarian cancer, pharma

New research from GlobalData has forecast that the worldwide market for ovarian cancer is set to expand at a compound …

News
flag-map_of_nigeria

Almost 400 Nigerian medical dispensaries shut down for sub-standard practice

October 28, 2019
Manufacturing and Production, Medical Communications, Sales and Marketing Nigeria, pharma

Nigeria has seen almost 400 of its medicine dispensaries shut down over “unethical practices and lack of compliance, it has …

News

European approval announced for Astellas’ Xospata in FLT3+ treatment-resistant acute myeloid leukaemia

October 28, 2019
Sales and Marketing Astellas, Xospata, leukaemia, pharma

Astellas has revealed that the European Commission has awarded marketing approval for Xospata (gilteritinib) as an oral, once-daily monotherapy for …

News
seattle_genetics

Seattle Genetics reports topline phase 3 HER2-Positive Breast Cancer Data

October 25, 2019
Medical Communications

Seattle Genetics, a strong competitor in the breast cancer space, has reported topline results in its phase 3 study evaluating …

News
top_10_photo

Top Ten most popular articles on Pharmafile.com this week

October 25, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

It’s another end of the week here at Pharmafile and here we run down our top 10 articles and features …

News
bbsrc

South West Biosciences to receive £18.5m boost

October 25, 2019

BioSciences in the UK has received a massive boost of £18.5 million awarded from the Biotechnology and Biological Sciences Research …

News
biogen_logo

Biogen plans Alzheimer’s drug approval after initial research failure

October 25, 2019
Medical Communications

Biogen is planning to seek approval for its experimental drug aducanumab, that could potentially be first to treat Alzheimer’s and …

News

FlyPharma tackles supply chain challenges and industry best practice at another successful conference

October 24, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing flypharma, pharma

For its fifth annual Europe conference, FlyPharma chose Copenhagen as its host city to address the latest supply chain challenges …

News
pliant

Novartis enters license agreement with Pliant Therapeutics for fibrosis assets

October 24, 2019
Research and Development

Novartis has signed a collaboration and license agreement with Pliant Therapeutics to develop and commercialise preclinical asset PLN-1474 which is …

News
alkermes

Alkermes to axe 160 jobs in cost-cutting restructure

October 24, 2019
Sales and Marketing

The Irish biopharma company expects to complete most of the job cuts by end of this year and will take …

News

Novartis receives EC label update approval for Cosentyx in ankylosing spondylitis

October 24, 2019
Research and Development

Novartis has announced that the European Commission has approved a label update for the up-titration of Cosentyx (secukunumab) to 300mg …

News
nhs_sign

Badly implemented electronic systems putting NHS patients at risk

October 24, 2019
Business Services

A new report has warned that poorly implemented electronic medication systems in the NHS could potentially lead to fatal medication …

News
gsk_l_rgb

GSK receives wider nod for Zejula as it competes with rival AstraZeneca

October 24, 2019
Research and Development

The US FDA has approved GlaxoSmithKline’s Zejula (niraparib) for the use in advanced ovarian, fallopian tube, or primary peritoneal cancer …

News
222170359

Damage control: How will pharma manage the health economic impacts of Brexit?

October 23, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing HEOR, brexit, health economics and outcomes research, pharma

When it comes to life sciences and patient outcomes, the UK’s destiny is inextricably tied to its relationship with the …

Feature
vertex-headquarters

FDA approves Vertex’s Trikafta in new indication, now potentially covering 90% of cystic fibrosis patients

October 23, 2019
Research and Development, Sales and Marketing FDA, Trikafta, Vertex, cystic fibrosis, pharma

The FDA has granted marketing authorisation to Vertex’s Trikafta (elexacaftor/tezacaftor/ivacaftor and ivacaftor) for the treatment of cystic fibrosis (CF), it …

News

New study shows Prozac no better than placebo in treating autism

October 23, 2019
Research and Development

A small study has found that the commonly prescribed medication for kids and teenagers with autism is no more effective …

News
opdivo_1_1

BMS’ Opdivo+Yervoy+Chemo combo shows superior overall survival in first-line lung cancer

October 23, 2019
Research and Development Bristol-Myers Squibb, Cancer, NSCLC, Yervoy, lung cancer, opdivo, pharma

Bristol Myers Squibb has lifted the curtain on new Phase 3 data for its blockbuster immunotherapy Opdivo (nivolumab), showing that …

News
biogen_logo

Biogen aiming for Aducanumab to slow Alzheimer’s progression

October 23, 2019
Research and Development

US firm Biogen is hoping for approval to bring about a treatment that could slow the onset of Alzheimer’s disease. …

News
The Gateway to Local Adoption Series

Latest content

Complement Therapeutics’ geographic atrophy treatment receives FDA Fast Track designation

January 22, 2026

PSI appoints David Allen as Country Manager for Canada

January 22, 2026

Qureight appoints Steven Bishop as Chief Medical Officer

January 21, 2026

Pierre Fabre Laboratories and Iktos announce oncology collaboration

January 21, 2026

Qureight appoints Rebecca Simmons as Chief Operating Officer

January 20, 2026